share_log

HC Wainwright & Co. Maintains Buy on Context Therapeutics, Lowers Price Target to $4

HC Wainwright & Co. Maintains Buy on Context Therapeutics, Lowers Price Target to $4

HC Wainwright & Co.维持对Context Therapeutics的买入,将目标股价下调至4美元
Moomoo 24/7 ·  03/21 12:21

HC Wainwright & Co. analyst Emily Bodnar maintains Context Therapeutics (NASDAQ:CNTX) with a Buy and lowers the price target from $5 to $4.

HC Wainwright & Co. 分析师艾米丽·博德纳尔维持Context Therapeutics(纳斯达克股票代码:CNTX)的买入并将目标股价从5美元下调至4美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发